BRK-B vs GBLI
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
GBLI exhibits significant financial deterioration, highlighted by a weak Piotroski F-Score of 3/9 and a severe earnings crash of -30.90% YoY. While the stock appears undervalued on a book-value basis (P/B 0.57) and relative to its Graham Number ($43.91), these metrics are offset by a low intrinsic value of $12.25 and a completely bearish technical trend (0/100). The high dividend payout ratio (80%) combined with declining earnings suggests the current 5% yield is unsustainable. Overall, the deterministic health scores signal a company in a state of fundamental decline despite the low valuation multiples.
Compare Another Pair
Related Comparisons
BRK-B vs GBLI: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-B) and Global Indemnity Group, LLC (GBLI) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.